Adults with type 2 diabetes will have a new alternative to daily insulin injections now that the U.S. Food and Drug Administration (FDA) approved a new once-a-week insulin injection.

From insulin inhalers to epinephrine nasal sprays, new delivery systems are making some lifesaving drugs easier to take.

New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, ...

SiBionics presented "See More, Act Earlier," connecting continuous sensing with future diabetes care. Three exhibition chapters shaped this vision: "See More: Beyond Glucose," covering glucose, ketone ...

The FDA just handed Eli Lilly a new diabetes approval, but the real debate is whether a once-weekly insulin needle moves the ...

The FDA has approved a once-weekly basal insulin to control glucose levels for adults with type 2 diabetes, Eli Lilly ...

Noninferiority but not superiority was achieved for CV outcomes, while orforglipron produced superior glycemic control and weight loss.

Insulin resistance (IR) is a central mechanism in hypertension (HTN) development, but its direct assessment is unfeasible in population studies. This cross-sectional study evaluated the association of ...

A first-of-its-kind Israeli study found that most young people with type 1 diabetes completed Jewish fasts safely, with insulin pump changes improving their chances of success.

The FDA has granted 510(k) clearance for an insulin titration algorithm that uses continuous glucose monitoring and insulin ...

Share on Pinterest Experts say California’s new affordable insulin program is a breakthrough for people with diabetes. Getty Images California has launched a program to manufacture and sell lower-cost ...

Insulin orchestrates systemic glucose homoeostasis by engaging a cell-surface tyrosine kinase receptor and activating a network of intracellular pathways. Upon insulin binding, the insulin receptor ...